Home/Filings/4/0001062993-24-002021
4//SEC Filing

Geist William 4

Accession 0001062993-24-002021

CIK 0000842023other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 6:36 PM ET

Size

18.2 KB

Accession

0001062993-24-002021

Insider Transaction Report

Form 4
Period: 2024-02-01
Geist William
PRESIDENT, PROTEIN SCIENCES
Transactions
  • Tax Payment

    Common Stock

    2024-02-01$68.54/sh1,111$76,1487,759 total
Holdings
  • Stock Options (Right to Buy)

    Exercise: $84.61Exp: 2030-08-15Common Stock (24,424 underlying)
    24,424
  • Stock Options (Right to Buy)

    Exercise: $84.61Exp: 2030-08-15Common Stock (30,059 underlying)
    30,059
  • Restricted Stock Units

    Common Stock (19,823 underlying)
    19,823
  • Restricted Stock Units

    Common Stock (3,360 underlying)
    3,360
  • Stock Options (Right to Buy)

    Exercise: $100.39Exp: 2029-02-01Common Stock (11,936 underlying)
    11,936
  • Stock Options (Right to Buy)

    Exercise: $100.39Exp: 2029-02-01Common Stock (15,912 underlying)
    15,912
  • Restricted Stock Units

    Common Stock (7,140 underlying)
    7,140
  • Stock Options (Right to Buy)

    Exercise: $94.52Exp: 2029-08-15Common Stock (22,200 underlying)
    22,200
  • Stock Options (Right to Buy)

    Exercise: $94.52Exp: 2029-08-15Common Stock (29,600 underlying)
    29,600
  • Restricted Stock Units

    Common Stock (9,074 underlying)
    9,074
Footnotes (9)
  • [F1]Includes 3,320 shares of restricted stock units for which the risk of forfeiture will lapse on 2/1/2025.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F3]Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F4]Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 3,976 shares vest on each of 2/1/2025 and 2/1/2026.
  • [F5]Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F6]Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
  • [F7]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  • [F8]Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
  • [F9]9,912 restricted stock units vest on 11/1/2024 and 9,911 restricted stock units vest on 11/1/2025.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001832210

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:36 PM ET
Size
18.2 KB